Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
95
-
Total 13F shares, excl. options
-
35.6M
-
Shares change
-
+1.29M
-
Total reported value, excl. options
-
$422M
-
Value change
-
+$16.1M
-
Put/Call ratio
-
0.5
-
Number of buys
-
37
-
Number of sells
-
-36
-
Price
-
$11.85
Significant Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q3 2017
116 filings reported holding TGTX - TG THERAPEUTICS, INC. - COMMON STOCK as of Q3 2017.
TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) has 95 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.6M shares
of 159M outstanding shares and own 22.42% of the company stock.
Largest 10 shareholders include FMR LLC (6.45M shares), BRIDGER MANAGEMENT, LLC (5.3M shares), BlackRock Inc. (3.3M shares), STATE STREET CORP (3.25M shares), FRANKLIN RESOURCES INC (2.37M shares), VANGUARD GROUP INC (2.26M shares), COLUMBUS CIRCLE INVESTORS (1.53M shares), JENNISON ASSOCIATES LLC (1.24M shares), UBS ASSET MANAGEMENT AMERICAS INC (1.09M shares), and SENZAR ASSET MANAGEMENT, LLC (864K shares).
This table shows the top 95 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.